Financials

  • Market Capitalization 195.01 M
  • Employee 61
  • Founded 1996
  • CEO N/A
  • Website www.acumenpharm.com
  • Headquarter Delaware, United States
  • FIGI BBG0058YJ317
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-1.05
Rapporto prezzo/fatturato
638.93

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3639
NERV
Minerva Neurosciences, Inc - Common Stock
4.27 USD0.00%-12.14%-7.38%+142.61%198.93 M USD
3642
VYGR
Voyager Therapeutics, Inc. - Common Stock
3.30 USD+1.85%-12.47%-7.04%-29.03%199.39 M USD
3652
WHWK
Whitehawk Therapeutics, Inc. - Common Stock
3.92 USD+2.08%-2.97%-6.67%+30.23%193.85 M USD
3658
PLX
Protalix BioTherapeutics, Inc. Common Stock
2.38 USD-0.83%+3.03%+15.53%-18.49%191.76 M USD

Notizie